Paul Pagano is the founder of LungLife AI. LungLife AI has raised $46M in total funding. Based in Thousand Oaks, United States.
Paul Pagano serves as the Interim CEO and Chief Scientific Officer of LungLife AI, a health tech startup. The company utilizes artificial intelligence and minimal blood draws for the early diagnosis of lung cancer. LungLife AI has secured $45.8 million in funding and partnered with Persistent Systems to develop AI and machine learning algorithms for its diagnostic technology.
Full founder directory · Investor directory · Company funding database · Fundraising library